Asunaprevir/daclatasvir and sofosbuvir/ledipasvir for recurrent hepatitis C following living donor liver transplantation

  • DAA for HCV-infected LDLT recipient
  • Kiyohiko Omichi, Nobuhisa Akamatsu, Kazuhiro Mori, Junichi Togashi, Junichi Arita, Junichi Kaneko, Kiyoshi Hasegawa, Yoshihiro Sakamoto, Norihiro Kokudo
  • Hepatology Research, December 2016, Wiley
  • DOI: 10.1111/hepr.12845

The authors haven't finished explaining this publication. If you are the author, sign in to claim or explain your work.

Read Publication

http://dx.doi.org/10.1111/hepr.12845

The following have contributed to this page: Dr Nobuhisa Akamatsu